Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exelixis Inc (NQ: EXEL ) 22.33 -0.13 (-0.58%) Streaming Delayed Price Updated: 11:00 AM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Exelixis Inc < Previous 1 2 3 4 5 6 7 8 9 Next > In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals. July 18, 2024 EXELIXIS INC (NASDAQ:EXEL): good value for what you're paying. Via Chartmill 7 Cheap Biotech Stocks With Major Upside Potential July 09, 2024 While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks. Via InvestorPlace When you look at NASDAQ:EXEL, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. June 27, 2024 When you look at EXELIXIS INC (NASDAQ:EXEL), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. Via Chartmill Don't overlook NASDAQ:EXEL—it's a hidden gem with strong fundamentals and an attractive price tag. June 06, 2024 EXELIXIS INC (NASDAQ:EXEL) appears to be flying under the radar despite its strong fundamentals. Via Chartmill 10 Health Care Stocks Whale Activity In Today's Session May 31, 2024 Via Benzinga The Analyst Verdict: Exelixis In The Eyes Of 5 Experts May 01, 2024 Via Benzinga Technical Signals Point to a Possible Breakout for EXELIXIS INC. April 24, 2024 EXELIXIS INC (NASDAQ:EXEL) Reveals Intriguing Technical Aspects. Here's What You Need to Know. Via Chartmill What Analysts Are Saying About Exelixis Stock April 10, 2024 Via Benzinga Over $8M Bet On This Health Care Stock? Check Out These 4 Stocks Insiders Are Buying May 31, 2024 Via Benzinga In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals. May 15, 2024 For those who appreciate value investing, EXELIXIS INC (NASDAQ:EXEL) is a compelling option with its solid fundamentals. Via Chartmill Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You? May 12, 2024 These stocks are both experts in their respective fields. Via The Motley Fool MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths' May 10, 2024 Despite MacroGenics' clinical activity, unexpected adverse events raise concerns. Analysts adjust ratings and price targets. Via Benzinga Just Say No to Drugs: 3 Pharma Stocks to Avoid May 08, 2024 Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios. Via InvestorPlace 2 Stocks Under $30 to Buy and Hold February 19, 2024 You don't need to be a millionaire to get started. Investing on a budget can work, too. Via The Motley Fool Exelixis (EXEL) Q1 2024 Earnings Call Transcript May 01, 2024 EXEL earnings call for the period ending March 31, 2024. Via The Motley Fool Topics Earnings Exposures Financial EXEL Stock Earnings: Exelixis Misses EPS, Misses Revenue for Q1 2024 April 30, 2024 EXEL stock results show that Exelixis missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace The Top 3 Biotech Stocks to Buy in April 2024 April 27, 2024 Learn about the top three biotech stocks to take advantage of these companies' promising futures and pharmaceutical advances. Via InvestorPlace NASDAQ:EXEL is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. April 24, 2024 EXELIXIS INC (NASDAQ:EXEL): good value for what you're paying. Via Chartmill NASDAQ:EXEL is an undervalued gem with solid fundamentals. March 29, 2024 For those who appreciate value investing, EXELIXIS INC (NASDAQ:EXEL) is a compelling option with its solid fundamentals. Via Chartmill 3 Biotech Stocks to Buy on the Dip: March 2024 March 27, 2024 Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. Via InvestorPlace 4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market March 23, 2024 Phenomenal deals can still be found, even with the Nasdaq Composite climbing to a new all-time high. Via The Motley Fool Topics Stocks Exposures US Equities 5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024 March 09, 2024 Things have been looking better for the biotech industry in 2024 after a decent performance in 2023. Here is a look at some biotech stocks that may provide stability to one's portfolio throughout the... Via Talk Markets 2 Biotech Stocks to Buy Hand Over Fist in March March 08, 2024 These stocks are worth buying in most months of the year. Via The Motley Fool 3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success March 06, 2024 With excellent financial health and great prospects, these three biotech stocks just may be the the next stars of the sector. Via InvestorPlace In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals. March 05, 2024 EXELIXIS INC (NASDAQ:EXEL) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. Via Chartmill 4 Thrilling Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market March 02, 2024 The growth-driven Nasdaq Composite has entered a new bull market, but plain-as-day deals can still be found. Via The Motley Fool Topics Stocks Exposures US Equities Around $4M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying February 23, 2024 Although U.S. stocks closed higher on Thursday, there were a few notable insider trades. Via Benzinga The 3 Best Biotech Stocks to Buy in February 2024 February 13, 2024 The best biotech stocks to buy offer consistent growth opportunities and resist the influence of singular drug successes. Via InvestorPlace In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals. February 13, 2024 For those who appreciate value investing, EXELIXIS INC (NASDAQ:EXEL) is a compelling option with its solid fundamentals. Via Chartmill 4 Appealing Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip February 10, 2024 The growth-driven Nasdaq Composite hasn't put the 2022 bear market entirely in the rearview mirror, which means opportunistic investors can still find bargains. Via The Motley Fool Topics Stocks Exposures US Equities < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.